Author

K. S. Fitzpatrick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

J. J. Taylor· 2 shared A. J. Remington· 1 shared C. K. Harms· 1 shared H. F. Moffett· 1 shared H. N. Degefu· 1 shared J. Boonyaratanakornkit· 1 shared J. Boonyaratankornkit· 1 shared K. Poljakov· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. J. Taylor

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Validation of ligand tetramers for the detection of antigen-specific lymphocytes

K. S. Fitzpatrick, H. N. Degefu, K. Poljakov, M. G. Bibby, A. J. Remington, M. D. Gray, J. Boonyaratanakornkit, P. C. Rosato, J. J. Taylor

The paper validates ligand tetramers for detecting antigen-specific lymphocytes, finding batch-to-batch variability and performance decline in certain fluorochromes.

bioRxiv · Oct 24, 2022Immunology

B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infection

H. F. Moffett, C. K. Harms, K. S. Fitzpatrick, M. R. Tooley, J. Boonyaratankornkit, J. J. Taylor

This study uses CRISPR/Cas9 to engineer B cells with pathogen-specific antibodies, providing durable protection against RSV in immunocompromised hosts.

bioRxiv · Feb 6, 2019Immunology